HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Hultman Selected Research

Sirolimus (Rapamycin)

12/2014Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Hultman Research Topics

Disease

3Stomach Neoplasms (Stomach Cancer)
12/2014 - 01/2012
2Peritoneal Neoplasms
05/2013 - 01/2012
1Neoplasms (Cancer)
12/2014
1Ovarian Neoplasms (Ovarian Cancer)
12/2014
1Colorectal Neoplasms (Colorectal Cancer)
12/2014

Drug/Important Bio-Agent (IBA)

1Sorafenib (BAY 43-9006)FDA Link
12/2014
1Sunitinib (Sutent)FDA Link
12/2014
1Cisplatin (Platino)FDA LinkGeneric
12/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014
1tyramine-deoxysorbitolIBA
12/2014
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2014
1Fluorescein (Funduscein)FDA LinkGeneric
12/2014
1Sirolimus (Rapamycin)FDA Link
12/2014
1Fluorouracil (Carac)FDA LinkGeneric
12/2014
1Bortezomib (Velcade)FDA Link
12/2014
1Docetaxel (Taxotere)FDA Link
12/2014
1Irinotecan (Camptosar)FDA LinkGeneric
12/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2014

Therapy/Procedure

2Hyperthermic Intraperitoneal Chemotherapy
05/2013 - 01/2012
2Drug Therapy (Chemotherapy)
05/2013 - 01/2012
2Cytoreduction Surgical Procedures
05/2013 - 01/2012
1Therapeutics
12/2014
1Neoadjuvant Therapy
05/2013